2022 Q4 Form 10-Q Financial Statement

#000175015522000116 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $18.87M $17.04M $23.70M
YoY Change -24.01% -28.13% -5.79%
Cost Of Revenue $29.44M $8.092M $8.789M
YoY Change 42.74% -7.93% -11.22%
Gross Profit -$10.57M $8.945M $14.92M
YoY Change -351.28% -40.03% -2.26%
Gross Profit Margin -56.02% 52.5% 62.92%
Selling, General & Admin $21.41M $11.03M $14.70M
YoY Change -12.16% -24.95% -20.75%
% of Gross Profit 123.33% 98.56%
Research & Development $1.471M
YoY Change -25.71%
% of Gross Profit 9.86%
Depreciation & Amortization $3.206M $1.822M $2.762M
YoY Change 14.62% -34.03% -1.36%
% of Gross Profit 20.37% 18.52%
Operating Expenses $21.41M $11.03M $23.90M
YoY Change -12.16% -53.84% -15.58%
Operating Profit -$31.98M -$3.909M -$8.985M
YoY Change 58.55% -56.49% -31.15%
Interest Expense -$3.580M -$4.000M $8.072M
YoY Change -1131.7% -149.55% -2406.29%
% of Operating Profit
Other Income/Expense, Net $440.0K $321.0K $110.0K
YoY Change -263.57% 191.82% -98.51%
Pretax Income -$35.14M -$7.588M -$913.0K
YoY Change -70.25% 731.11% -86.0%
Income Tax $91.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$35.23M -$7.588M -$913.0K
YoY Change -70.21% 731.11% -86.04%
Net Earnings / Revenue -186.71% -44.54% -3.85%
Basic Earnings Per Share -$0.05 -$0.01
Diluted Earnings Per Share -$0.23 -$0.05 -$6.497K
COMMON SHARES
Basic Shares Outstanding 151.6M shares 145.5M shares 140.5M shares
Diluted Shares Outstanding 145.3M shares 140.5M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.96M $16.51M $21.07M
YoY Change 243.51% -21.62% -68.03%
Cash & Equivalents $66.96M $16.51M $21.07M
Short-Term Investments
Other Short-Term Assets $7.998M $4.530M $9.004M
YoY Change -1.2% -49.69% -33.3%
Inventory $26.95M $50.60M $63.51M
Prepaid Expenses $2.612M
Receivables $1.847M $2.044M $4.429M
Other Receivables $573.0K $495.0K $13.27M
Total Short-Term Assets $103.8M $74.18M $111.3M
YoY Change 8.3% -33.34% -32.1%
LONG-TERM ASSETS
Property, Plant & Equipment $29.33M $31.09M $60.91M
YoY Change -18.72% -48.96% 4.65%
Goodwill $0.00
YoY Change
Intangibles $1.771M $2.018M
YoY Change -37.71%
Long-Term Investments $0.00
YoY Change
Other Assets $5.770M $6.016M $15.12M
YoY Change 179.83% -60.2% 196.37%
Total Long-Term Assets $83.88M $66.34M $175.5M
YoY Change 10.8% -62.2% 5.34%
TOTAL ASSETS
Total Short-Term Assets $103.8M $74.18M $111.3M
Total Long-Term Assets $83.88M $66.34M $175.5M
Total Assets $187.6M $140.5M $286.8M
YoY Change 9.4% -51.0% -13.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.018M $2.584M $7.574M
YoY Change -20.42% -65.88% 42.91%
Accrued Expenses $6.899M $7.435M $9.811M
YoY Change -27.91% -24.22% -28.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $445.0K $3.128M $6.120M
YoY Change -91.98% -48.89% -61.27%
Total Short-Term Liabilities $21.43M $13.15M $23.51M
YoY Change 6.23% -44.07% -33.41%
LONG-TERM LIABILITIES
Long-Term Debt $37.43M $18.51M $21.04M
YoY Change 79.21% -12.02% -19.71%
Other Long-Term Liabilities $51.28M $2.000K $260.0K
YoY Change 427258.33% -99.23% -89.6%
Total Long-Term Liabilities $88.71M $2.000K $21.30M
YoY Change 739150.0% -99.99% -25.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.43M $13.15M $23.51M
Total Long-Term Liabilities $88.71M $2.000K $21.30M
Total Liabilities $110.1M $31.66M $44.80M
YoY Change 168.19% -29.34% -30.0%
SHAREHOLDERS EQUITY
Retained Earnings -$247.9M -$212.7M
YoY Change 31.45%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $77.51M $108.9M $242.0M
YoY Change
Total Liabilities & Shareholders Equity $187.6M $140.5M $286.8M
YoY Change 9.4% -51.0% -13.23%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$35.23M -$7.588M -$913.0K
YoY Change -70.21% 731.11% -86.04%
Depreciation, Depletion And Amortization $3.206M $1.822M $2.762M
YoY Change 14.62% -34.03% -1.36%
Cash From Operating Activities -$2.716M $1.685M -$7.157M
YoY Change -56.44% -123.54% -66.82%
INVESTING ACTIVITIES
Capital Expenditures -$146.0K -$78.00K -$820.0K
YoY Change -82.41% -90.49% -93.25%
Acquisitions
YoY Change
Other Investing Activities $306.0K $354.0K $119.0K
YoY Change 133.59% 197.48% -89.08%
Cash From Investing Activities $452.0K $276.0K -$701.0K
YoY Change -164.66% -139.37% -93.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.918M
YoY Change 1818.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.71M -265.0K 1.831M
YoY Change 883.65% -114.47% -241.94%
NET CHANGE
Cash From Operating Activities -2.716M 1.685M -7.157M
Cash From Investing Activities 452.0K 276.0K -701.0K
Cash From Financing Activities 52.71M -265.0K 1.831M
Net Change In Cash 50.45M 1.696M -6.027M
YoY Change -3303.17% -128.14% -82.23%
FREE CASH FLOW
Cash From Operating Activities -$2.716M $1.685M -$7.157M
Capital Expenditures -$146.0K -$78.00K -$820.0K
Free Cash Flow -$2.570M $1.763M -$6.337M
YoY Change -52.45% -127.82% -32.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001750155
dei Security12g Title
Security12gTitle
Common stock, no par value
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q1 cweb Business Combination Purchase Option Term
BusinessCombinationPurchaseOptionTerm
P5Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56364
dei Entity Registrant Name
EntityRegistrantName
Charlotte's Web Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1508633
dei Entity Address Address Line1
EntityAddressAddressLine1
700 Tech Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Louisville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80027
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
617-7303
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
151628652 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16513000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19494000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2044000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4882000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
495000 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
495000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
50599000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
52077000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4530000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8095000 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
10764000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
74181000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
95807000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31087000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36085000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17079000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20679000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2018000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2843000 usd
CY2022Q3 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
9100000 usd
CY2021Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
13000000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1037000 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1037000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6016000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2062000 usd
CY2022Q3 us-gaap Assets
Assets
140518000 usd
CY2021Q4 us-gaap Assets
Assets
171513000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2584000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5049000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7435000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9570000 usd
CY2022Q3 cweb Cultivation Liabilities Current
CultivationLiabilitiesCurrent
812000 usd
CY2021Q4 cweb Cultivation Liabilities Current
CultivationLiabilitiesCurrent
3448000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2316000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2103000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13147000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20170000 usd
CY2022Q3 cweb Cultivation Liabilities Noncurrent
CultivationLiabilitiesNoncurrent
0 usd
CY2021Q4 cweb Cultivation Liabilities Noncurrent
CultivationLiabilitiesNoncurrent
385000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18507000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20500000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
31656000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
41067000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
145509372 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145509372 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144659964 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144659964 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 cweb Proportionate Voting Stock Value Issued
ProportionateVotingStockValueIssued
0 usd
CY2021Q4 cweb Proportionate Voting Stock Value Issued
ProportionateVotingStockValueIssued
0 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
321559000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319059000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212698000 usd
us-gaap Gross Profit
GrossProfit
44379000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11032000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24299000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-188614000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
108862000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
130446000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140518000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171513000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17037000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23704000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55271000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71263000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8092000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8789000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25291000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26884000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
8945000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
14915000 usd
us-gaap Gross Profit
GrossProfit
29980000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48646000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73263000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1822000 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1822000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3909000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9384000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20488000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28884000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
321000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
304000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
320000 usd
CY2022Q3 cweb Change In Fair Value Of Financial Instruments And Other Gain Loss
ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss
-4000000 usd
CY2021Q3 cweb Change In Fair Value Of Financial Instruments And Other Gain Loss
ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss
8459000 usd
cweb Change In Fair Value Of Financial Instruments And Other Gain Loss
ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss
-3900000 usd
cweb Change In Fair Value Of Financial Instruments And Other Gain Loss
ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss
9082000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7588000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-815000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24084000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19482000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7588000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-777000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24084000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19474000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145334992 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145334992 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140521244 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140521244 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145203515 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145203515 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140054738 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140054738 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
130446000 usd
CY2022Q1 cweb Stock Issued During Period Value Asset Acquisition
StockIssuedDuringPeriodValueAssetAcquisition
165000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8626000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
123152000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
643000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7870000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
115912000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-59000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
664000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7588000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
108862000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
254242000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000 usd
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
112000 usd
CY2021Q1 cweb Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
441000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
832000 usd
CY2021Q1 cweb Stock Issued During Period Value Asset Acquisition
StockIssuedDuringPeriodValueAssetAcquisition
360000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12774000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
243019000 usd
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26000 usd
CY2021Q2 cweb Stock Issued During Period Value Asset Acquisition
StockIssuedDuringPeriodValueAssetAcquisition
363000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
839000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
994000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5923000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
239266000 usd
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5000 usd
CY2021Q3 cweb Stock Issued During Period Value Asset Acquisition
StockIssuedDuringPeriodValueAssetAcquisition
196000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1918000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1383000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-777000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
241981000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24084000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19474000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5762000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8228000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1822000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
-3900000 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
9082000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-89000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
590000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1857000 usd
us-gaap Inventory Write Down
InventoryWriteDown
178000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2686000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4128000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
97000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-267000 usd
cweb Settlement Of Cultivation Liability
SettlementOfCultivationLiability
582000 usd
cweb Settlement Of Cultivation Liability
SettlementOfCultivationLiability
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1877000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2928000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
226000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-112000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
876000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3086000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-112000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
1665000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
81000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4238000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-439000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-10764000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-523000 usd
cweb Increase Decrease In Cultivation Liabilities
IncreaseDecreaseInCultivationLiabilities
-2471000 usd
cweb Increase Decrease In Cultivation Liabilities
IncreaseDecreaseInCultivationLiabilities
-7166000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4167000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
6000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2599000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23324000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
411000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4088000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
354000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
9000 usd
cweb Payments To Acquire Notes Receivable Net Of Proceeds From Collection
PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection
0 usd
cweb Payments To Acquire Notes Receivable Net Of Proceeds From Collection
PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection
468000 usd
cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
0 usd
cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-521000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11090000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-61000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2896000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-264000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-246000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-325000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2680000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2981000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31734000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19494000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52803000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16513000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21069000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2490000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17037000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23704000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55271000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71263000 usd
CY2022Q3 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
9100000 usd
CY2021Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
13000000 usd
CY2021Q1 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd
CY2021Q1 cweb Business Combination Purchase Option Extension Term
BusinessCombinationPurchaseOptionExtensionTerm
P2Y
CY2021Q1 cweb Class Of Warrant Or Right Percentage Of Outstanding Shares
ClassOfWarrantOrRightPercentageOfOutstandingShares
0.10
CY2021Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P60D
CY2022Q3 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-4000000 usd
cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-3900000 usd
CY2021Q3 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
5730000 usd
cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
4900000 usd
CY2022Q3 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
9100000 usd
CY2021Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
13000000 usd
CY2022Q2 cweb Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
5750000 shares
CY2022Q2 cweb Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
6.27
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2638000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4081000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
37444000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
38249000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12617000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
15189000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14865000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13974000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
64926000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
67412000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
14327000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
15335000 usd
CY2022Q3 cweb Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
50599000 usd
CY2021Q4 cweb Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
52077000 usd
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000 usd
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
867000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3415000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3205000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2896000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2172000 usd
CY2022Q3 cweb Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
15595000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28150000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7327000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20823000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2316000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18507000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1822000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1822000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q4 cweb Cultivation Liabilities Current
CultivationLiabilitiesCurrent
3448000 usd
CY2021Q4 cweb Cultivation Liabilities Noncurrent
CultivationLiabilitiesNoncurrent
385000 usd
CY2021Q4 cweb Cultivation Liabilities
CultivationLiabilities
3833000 usd
cweb Cultivation Liability Costs Incurred Current
CultivationLiabilityCostsIncurredCurrent
169000 usd
cweb Cultivation Liability Costs Incurred Noncurrent
CultivationLiabilityCostsIncurredNoncurrent
0 usd
cweb Cultivation Liability Costs Incurred
CultivationLiabilityCostsIncurred
169000 usd
CY2022Q3 cweb Cultivation Liabilities Current
CultivationLiabilitiesCurrent
812000 usd
CY2022Q3 cweb Cultivation Liabilities Noncurrent
CultivationLiabilitiesNoncurrent
0 usd
cweb Cultivation Liability Settlement Payments Current
CultivationLiabilitySettlementPaymentsCurrent
2640000 usd
cweb Cultivation Liability Settlement Payments Noncurrent
CultivationLiabilitySettlementPaymentsNoncurrent
0 usd
cweb Cultivation Liability Settlement Payments
CultivationLiabilitySettlementPayments
2640000 usd
cweb Cultivation Liability Settlement Reduction Current
CultivationLiabilitySettlementReductionCurrent
582000 usd
cweb Cultivation Liability Settlement Reduction Noncurrent
CultivationLiabilitySettlementReductionNoncurrent
0 usd
cweb Cultivation Liability Settlement Reduction
CultivationLiabilitySettlementReduction
582000 usd
cweb Cultivation Liability Interest Expense Current
CultivationLiabilityInterestExpenseCurrent
32000 usd
cweb Cultivation Liability Interest Expense Noncurrent
CultivationLiabilityInterestExpenseNoncurrent
0 usd
cweb Cultivation Liability Interest Expense
CultivationLiabilityInterestExpense
32000 usd
cweb Cultivation Liability Conversion To Short Term Borrowing Current
CultivationLiabilityConversionToShortTermBorrowingCurrent
-385000 usd
cweb Cultivation Liability Conversion To Short Term Borrowing Noncurrent
CultivationLiabilityConversionToShortTermBorrowingNoncurrent
385000 usd
cweb Cultivation Liability Conversion To Short Term Borrowing
CultivationLiabilityConversionToShortTermBorrowing
0 usd
CY2022Q3 cweb Cultivation Liabilities
CultivationLiabilities
812000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142335464 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142335464 shares
CY2021Q4 cweb Proportionate Voting Stock Shares Issued
ProportionateVotingStockSharesIssued
0 shares
CY2021Q4 cweb Proportionate Voting Stock Shares Outstanding
ProportionateVotingStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 cweb Proportionate Voting Stock Shares Outstanding
ProportionateVotingStockSharesOutstanding
0 shares
CY2021Q4 cweb Proportionate Voting Stock Shares Outstanding
ProportionateVotingStockSharesOutstanding
0 shares
CY2022Q3 cweb Proportionate Voting Stock Shares Issued
ProportionateVotingStockSharesIssued
0 shares
CY2021Q4 cweb Proportionate Voting Stock Shares Issued
ProportionateVotingStockSharesIssued
0 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6983140 shares
CY2021Q4 cweb Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
7.86
cweb Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
cweb Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0
cweb Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
cweb Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
0
cweb Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
6983140 shares
cweb Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
7.86
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q3 cweb Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q2 cweb Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1233140 shares
CY2022Q2 cweb Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
15.29
CY2022Q2 cweb Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
5750000 shares
CY2022Q2 cweb Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
6.27
cweb Proportionate Voting Stock Conversion Ratio
ProportionateVotingStockConversionRatio
400
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7588000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-777000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24084000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19474000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145334992 shares
CY2021Q3 cweb Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingBasic
120270444 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145203515 shares
cweb Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingBasic
112688338 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic
0 shares
CY2021Q3 cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic
50627 shares
cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic
0 shares
cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Basic
WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic
68416 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145334992 shares
CY2021Q3 cweb Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingDiluted
120270444 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145203515 shares
cweb Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingDiluted
112688338 shares
CY2022Q3 cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted
0 shares
CY2021Q3 cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted
50627 shares
cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted
0 shares
cweb Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted
WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted
68416 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 cweb Earnings Per Proportionate Voting Share Basic
EarningsPerProportionateVotingShareBasic
0
CY2022Q3 cweb Earnings Per Proportionate Voting Share Diluted
EarningsPerProportionateVotingShareDiluted
0
CY2021Q3 cweb Earnings Per Proportionate Voting Share Basic
EarningsPerProportionateVotingShareBasic
-2.21
CY2021Q3 cweb Earnings Per Proportionate Voting Share Diluted
EarningsPerProportionateVotingShareDiluted
-2.21
cweb Earnings Per Proportionate Voting Share Basic
EarningsPerProportionateVotingShareBasic
0
cweb Earnings Per Proportionate Voting Share Diluted
EarningsPerProportionateVotingShareDiluted
0
cweb Earnings Per Proportionate Voting Share Basic
EarningsPerProportionateVotingShareBasic
-55.62
cweb Earnings Per Proportionate Voting Share Diluted
EarningsPerProportionateVotingShareDiluted
-55.62
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7468731 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14237172 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.858
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.825
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Price
SharePrice
0.43
CY2021Q3 us-gaap Share Price
SharePrice
2.18
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3343883 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.16
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M14D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1039229 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3813579 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.11
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2532201 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.32
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4625261 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M10D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
170184 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1579296 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M28D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14184 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.11
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.63
cweb Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice
0
cweb Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice
3.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
881000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
354000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1816851 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3380777 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1748387 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
440863 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.00
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod
164908 shares
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriodWeightedAverageGrantDateFairValue
1.58
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2843470 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.99
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
664000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1579000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2686000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4128000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6114000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
10841000 usd
CY2022Q3 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4106000 usd
CY2020Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
1000000000 usd
CY2020Q4 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.0325
CY2021Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
1037000 usd
CY2022Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
1037000 usd
CY2021Q1 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd

Files In Submission

Name View Source Status
0001750155-22-000116-index-headers.html Edgar Link pending
0001750155-22-000116-index.html Edgar Link pending
0001750155-22-000116.txt Edgar Link pending
0001750155-22-000116-xbrl.zip Edgar Link pending
cweb-20220930.htm Edgar Link pending
cweb-20220930.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
cweb-20220930_def.xml Edgar Link unprocessable
cweb-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cweb-20220930_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cweb-20220930_cal.xml Edgar Link unprocessable
cweb-20220930_pre.xml Edgar Link unprocessable